Arteris, Inc. (NASDAQ:AIP – Get Free Report) major shareholder Bayview Legacy, Llc sold 50,000 shares of Arteris stock in a transaction on Wednesday, October 8th. The shares were sold at an average price of $13.07, for a total value of $653,500.00. Following the completion of the sale, the insider directly owned 9,689,071 shares of the company’s stock, valued at $126,636,157.97. The trade was a 0.51% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.
Bayview Legacy, Llc also recently made the following trade(s):
- On Monday, October 6th, Bayview Legacy, Llc sold 100,000 shares of Arteris stock. The shares were sold at an average price of $13.10, for a total value of $1,310,000.00.
- On Tuesday, August 5th, Bayview Legacy, Llc sold 50,000 shares of Arteris stock. The shares were sold at an average price of $13.12, for a total value of $656,000.00.
Arteris Trading Down 5.5%
Shares of NASDAQ AIP opened at $12.39 on Friday. Arteris, Inc. has a twelve month low of $5.46 and a twelve month high of $14.58. The stock has a fifty day simple moving average of $9.98 and a 200-day simple moving average of $8.60. The stock has a market capitalization of $528.43 million, a PE ratio of -15.11 and a beta of 1.45.
Wall Street Analyst Weigh In
Several research analysts recently commented on AIP shares. TD Cowen boosted their target price on Arteris from $12.00 to $15.00 and gave the stock a “buy” rating in a research note on Wednesday, August 6th. Weiss Ratings reissued a “sell (d-)” rating on shares of Arteris in a research note on Wednesday. Finally, Wall Street Zen raised Arteris from a “sell” rating to a “hold” rating in a research note on Monday, September 15th. Three analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $15.00.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in the business. Raymond James Financial Inc. acquired a new position in shares of Arteris during the 2nd quarter worth about $32,000. GAMMA Investing LLC boosted its position in shares of Arteris by 11,823.3% during the 1st quarter. GAMMA Investing LLC now owns 5,127 shares of the company’s stock worth $350,000 after acquiring an additional 5,084 shares in the last quarter. Bank of America Corp DE boosted its position in shares of Arteris by 11.8% during the 2nd quarter. Bank of America Corp DE now owns 57,093 shares of the company’s stock worth $544,000 after acquiring an additional 6,008 shares in the last quarter. CWM LLC boosted its position in shares of Arteris by 4,810.1% during the 1st quarter. CWM LLC now owns 10,213 shares of the company’s stock worth $71,000 after acquiring an additional 10,005 shares in the last quarter. Finally, Savant Capital LLC acquired a new position in shares of Arteris during the 2nd quarter worth about $97,000. 64.36% of the stock is owned by institutional investors and hedge funds.
About Arteris
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Featured Articles
- Five stocks we like better than Arteris
- How to Calculate Stock Profit
- 3 Heavily Shorted Stocks That Could Pop on Rate Cuts
- Earnings Per Share Calculator: How to Calculate EPS
- Broadcom Gets Second $420 Target as CPO Win Boosts Outlook
- What is a buyback in stocks? A comprehensive guide for investors
- PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.